Carbamoyl-Phosphate Synthase I Deficiency Disease
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Disease or Syndrome
18
0.870
definitive
1.000
18
1986
2019
Urea Cycle Disorders, Inborn
group
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Disease or Syndrome
14
0.070
None
1.000
7
2007
2018
Herpes zoster disease
group
Infections
Disease or Syndrome
51
10
0.040
None
1.000
4
2014
2019
×
CUI:
C0030193
Disease:
Pain
Pain
phenotype
Pathological Conditions, Signs and Symptoms
Sign or Symptom
1554
196
0.040
None
1.000
4
2014
2018
Carbamoyl Phosphate Synthase 1 Deficiency
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Disease or Syndrome
3
0.310
None
1.000
3
1993
2007
Postherpetic neuralgia
disease
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
Disease or Syndrome
24
1
0.030
None
1.000
3
2014
2019
HHH syndrome
disease
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Disease or Syndrome
8
21
0.030
None
1.000
3
2018
2019
Liver carcinoma
disease
Digestive System Diseases; Neoplasms
Neoplastic Process
5725
942
0.030
None
1.000
3
2002
2014
Adenocarcinoma of lung (disorder)
disease
Neoplasms
Neoplastic Process
2438
563
0.020
None
1.000
2
2017
2019
Liver Failure
disease
Digestive System Diseases
Disease or Syndrome
293
20
0.200
None
1.000
2
1996
2002
Ornithine carbamoyltransferase deficiency
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
Disease or Syndrome
17
142
0.020
None
1.000
2
2001
2019
Liver Cirrhosis, Experimental
disease
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
Experimental Model of Disease
870
0.500
None
1.000
2
2005
2007
Neoplasms
group
Neoplasms
Neoplastic Process
10161
1644
0.020
None
1.000
2
2017
2019
Metabolic Diseases
group
Nutritional and Metabolic Diseases
Disease or Syndrome
945
50
0.020
None
1.000
2
1998
2019
Drug-Induced Liver Disease
phenotype
Digestive System Diseases; Chemically-Induced Disorders
Disease or Syndrome
537
29
0.310
None
1.000
2
2015
2015
Intrahepatic Cholangiocarcinoma
disease
Neoplasms
Neoplastic Process
470
19
0.020
None
1.000
2
2015
2019
Condition, Preneoplastic
disease
Neoplasms
Neoplastic Process
122
0.300
None
1.000
1
2012
2012
Obesity
disease
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
Disease or Syndrome
2821
1111
0.200
None
1.000
1
1997
1997
Neuralgia
phenotype
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
Sign or Symptom
767
16
0.010
None
1.000
1
2018
2018
Liver and Intrahepatic Biliary Tract Carcinoma
disease
Digestive System Diseases; Neoplasms
Neoplastic Process
1395
73
0.010
None
1.000
1
2011
2011
Tumor Progression
phenotype
Pathological Conditions, Signs and Symptoms
Neoplastic Process
3865
72
0.010
None
1.000
1
2019
2019
Hepatitis, Drug-Induced
disease
Digestive System Diseases; Chemically-Induced Disorders
Disease or Syndrome
418
0.300
None
1.000
1
2015
2015
Hereditary orotic aciduria, type 1
disease
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
Disease or Syndrome
3
3
0.010
None
1.000
1
2018
2018
Mental Retardation
disease
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
Mental or Behavioral Dysfunction
505
98
0.010
None
1.000
1
2015
2015
Liver Neoplasms, Experimental
phenotype
Digestive System Diseases; Neoplasms
Neoplastic Process; Experimental Model of Disease
152
0.200
None
1.000
1
1988
1988